Genetic Technologies Quick Ratio 2010-2022 | GENE

Historical quick ratio values for Genetic Technologies (GENE) over the last 10 years.
Genetic Technologies Quick Ratio Historical Data
Date Current Assets - Inventory Current Liabilities Quick Ratio
2022-06-30 $0.01B $0.00B 3.76
2021-12-31 $0.01B $0.00B 5.96
2021-06-30 $0.02B $0.00B 15.77
2020-12-31 $0.01B $0.00B 14.48
2020-06-30 $0.01B $0.00B 10.81
2019-12-31 $0.00B $0.00B 2.90
2019-06-30 $0.00B $0.00B 0.00
2018-12-31 $0.00B $0.00B 0.00
2018-06-30 $0.00B $0.00B 0.00
2017-12-31 $0.00B $0.00B 0.00
2017-06-30 $0.00B $0.00B 0.00
2016-12-31 $0.00B $0.00B 0.00
2016-06-30 $0.00B $0.00B 0.00
2015-12-31 $0.00B $0.00B 0.00
2015-06-30 $0.00B $0.00B 0.00
2014-12-31 $0.00B $0.00B 0.00
2014-06-30 $0.00B $0.00B 0.00
2013-12-31 $0.00B $0.00B 0.00
2013-06-30 $0.00B $0.00B 0.00
2012-12-31 $0.00B $0.00B 0.00
2012-06-30 $0.00B $0.00B 0.00
2011-12-31 $0.00B $0.00B 0.00
2011-06-30 $0.00B $0.00B 0.00
2010-12-31 $0.01B $0.00B 4.21
2010-06-30 $0.00B $0.00B 0.00
2009-12-31 $0.00B $0.00B 0.00
2009-06-30 $0.00B $0.00B 0.00
Sector Industry Market Cap Revenue
Medical Medical - Biomedical and Genetics $0.028B $0.005B
Genetic Technologies was the first company in the world to recognize important new applications for `non-coding` DNA (DeoxyriboNucleic Acid). The Company has since been granted patents securing intellectual property rights for particular uses of non-coding DNA in genetic analysis and gene mapping across all genes in all multicellular species.
Stock Name Country Market Cap PE Ratio
Bristol Myers Squibb (BMY) United States $158.293B 9.67
GSK (GSK) United Kingdom $71.300B 9.41
Bio-Rad Laboratories (BIO.B) United States $12.069B 28.64
QIAGEN (QGEN) Netherlands $11.249B 19.20
Ginkgo Bioworks Holdings (DNA) United States $3.996B 0.00
Myovant Sciences (MYOV) United Kingdom $2.614B 0.00
Arcus Biosciences (RCUS) United States $1.485B 22.29
Biohaven (BHVN) United States $1.240B 0.00
Emergent Biosolutions (EBS) United States $0.697B 5.48
ADC Therapeutics SA (ADCT) Switzerland $0.356B 0.00
Enzo Biochem (ENZ) United States $0.070B 0.00
Ambrx Biopharma (AMAM) United States $0.070B 0.00
SQZ Biotechnologies (SQZ) United States $0.024B 0.00
Gelesis Holdings (GLS) United States $0.024B 0.00